Loading…
Fairness to Pet Owners Act of 2014
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,002 other S bills in the 113th — cohort avg 39d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2015 · first_quarter · Pharmacy
Discussions with Congressional staff, FDA and USDA regarding the use of antimicrobials in food-producing animals, particularly with respect to H.R. 1552 (Preservation of Antibiotics for Medical Treatment Act) S. 621 (Preventing Antibiotics Resistance Act), and FDA's strategy (GRI #209 and VFD Rule) Discussions with Congressional staff FDA and Government Accountability Office to express the need for compounding of medications for use in animals Inquiries to, and discussions with Congressional staff and Federal Trade Commission on veterinary pet prescriptions, particularly regarding legislation that might look like a bill from 113th Congress [H.R. 4023/S. 2756 (Fairness to Pet Owners Act)] Inquiry to Sen. Vitter's office for information on S. 190, Imported Seafood Safety Act Meeting planning with Senate and House offices regarding bans on use of horse race day medications
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $220,000 · Firm income: Not reported
Government targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2014 · fourth_quarter · Animals
HR 4023, and S 2756 Fairness to Petowners Act
Client expense: $300,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Animals
S. 2756/H.R. 4023, Fairness to Pet Owners Act of 2014
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Pharmacy
H.R. 1150 Preservation of Antibiotics for Medical Treatment Act S. 1256 Preventing Antibiotics Resistance Act Animal Compounding Veterinary Feed Directive Discussions with Congressional staff and FDA regarding the use of antimicrobials in food-producing animals, particularly with respect to H.R. 1150 (Preservation of Antibiotics for Medical Treatment Act), S. 1256 (Preventing Antibiotic Resistance Act), and FDA's strategy (GRI #209 and VFD Rule) Discussions with Congressional staff, FDA and Government Accountability Office to express the need for compounding of medications for use in animals. Inquiries to and discussions with Congressional staff and Federal Trade Commission on veterinary pet prescriptions, particularly regarding H.R. 4023/S. 2756 (Fairness to Pet Owners Act)
Client expense: $190,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Federal Trade Commission (FTC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2014 · third_quarter · Animals
S. 2756/H.R. 4023, Fairness to Pet Owners Act of 2014
Client expense: Not reported · Firm income: $10,000
Government targets: SENATE
2014 · third_quarter · Pharmacy
H.R. 1150 Preservation of Antibiotics for Medical Treatment Act S. 1256 Prevent Antibiotic Resistance Act H.R. 1528/S. 1171 Veterinary Medicine Mobility Act H.R. 4023 Fairness to Pet Owners Act Animal Compounding Veterinary Feed Directive Discussions with Congressional staff about DEA regulations impeding practice of veterinary medicine; seeking passage of legislation to change underlying statute (H.R. 1528) Discussions with Congressional staff and FDA regarding the use of antimicrobials in feed producing animals, particularly with respect to H.R. 1150 (Preservation of Antibiotics for Medical Treatment Act), S. 1256 (Preventing Antibiotic Resistance Act), and FDA's strategy. Discussions with Congressional staff, FDA and Government Accountability Office expressing the need for compounding of medications for use in animals. Inquiries to and discussions with Congressional staff and Federal Trade Commission on veterinary pet prescriptions, particularly regarding H.R. 4023/S. 2756 (Fairness to Pet Owners Act)
Client expense: $210,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2014 · third_quarter · Pharmacy
H.R. 1150 Preservation of Antibiotics for Medical Treatment Act S. 1256 Prevent Antibiotic Resistance Act H.R. 1528/S. 1171 Veterinary Medicine Mobility Act H.R. 4023 Fairness to Pet Owners Act Animal Compounding Veterinary Feed Directive Discussions with Congressional staff about DEA regulations impeding practice of veterinary medicine; seeking passage of legislation to change underlying statute (H.R. 1528) Discussions with Congressional staff and FDA regarding the use of antimicrobials in feed producing animals, particularly with respect to H.R. 1150 (Preservation of Antibiotics for Medical Treatment Act), S. 1256 (Preventing Antibiotic Resistance Act), and FDA's strategy. Discussions with Congressional staff, FDA and Government Accountability Office expressing the need for compounding of medications for use in animals. Inquiries to and discussions with Congressional staff and Federal Trade Commission on veterinary pet prescriptions, particularly regarding H.R. 4023/S. 2756 (Fairness to Pet Owners Act)
Client expense: $210,000 · Firm income: Not reported
2014 · third_quarter · Pharmacy
FDA approval process; Unlicensed veterinary biologicals: Categorical Exclusions from Environmental Risk Assessments, Issues related to illegal drug manufacturing under the guise of compounding, HR4023 & S2756 - Fairness to Pet Owners Act
Client expense: $40,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Agriculture, Dept of (USDA), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE